2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2022 AHA/ACC/HFSA Guideline for the management of heart failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Since the publication of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, there have been several randomised controlled trials that should change patient management ahead of the next scheduled full guideline. This 2023 Focused Update addresses changes in recommendations for the treatment of HF because of this new evidence. We considered new, published evidence up to 31 March 2023. After considering and discussing many new major randomised controlled clinical trials and meta-analyses, the Task Force voted to include those that would lead to Class IIa and I recommendations. This has led to us updating some of our guidance for the treatment of HFmrEF, HFpEF, comorbidities and Acute HF.


Read full Guideline